Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells

Bone

Volumn 33, Issue 3, 2003, Pages 426-433

  Marrony, S ^a   Bassilana, F ^a,b   Seuwen, K ^a   Keller, H ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLECALCIFEROL; COMPLEMENTARY DNA; MESSENGER RNA; PLACENTAL GROWTH FACTOR; PLACENTAL GROWTH FACTOR 1; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME CELL; OSSIFICATION; OSTEOBLAST; OSTEOSARCOMA CELL; PLACENTA; PLACENTAL GROWTH FACTOR 1 GENE; PLACENTAL GROWTH FACTOR GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL;

EID: 0042333448     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00195-9     Document Type: Article

References (51)

1. Li R.H., Wozney J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19:2001;255-265.
2. Wang E.A., Rosen V., D'Alessandro J.S., Bauduy M., Cordes P., Harada T. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA. 87:1990;2220-2224.
3. Ahrens M., Ankenbauer T., Schroder D., Hollnagel A., Mayer H., Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol. 12:1993;871-880.
4. Lecanda F., Avioli L.V., Cheng S.L. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem. 67:1997;386-396.
5. Rickard D.J., Sullivan T.A., Shenker B.J., Leboy P.S., Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol. 161:1994;218-228.
6. Thies R.S., Bauduy M., Ashton B.A., Kurtzberg L., Wozney J.M., Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology. 130:1992;1318-1324.
7. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J.M., et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun. 220:1996;366-371.
8. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
9. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276:1997;71-74.
10. Sottile V., Halleux C., Bassilana F., Keller H., Seuwen K. Stem cell characteristics of human trabecular bone-derived cells. Bone. 30:2002;699-704.
11. Chaudhari A., Ron E., Rethman M.P. Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Mol Cell Biochem. 67:1997;31-39.
12. Yamamoto N., Akiyama S., Katagiri T., Namiki M., Kurokawa T., Suda T. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun. 238:1997;574-580.
13. Gimble J.M., Morgan C., Kelly K., Wu X., Dandapani V., Wang C.S., Rosen V. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem. 58:1995;393-402.
14. Gori F., Thomas T., Hicok K.C., Spelsberg T.C., Riggs B.L. Differentiation of human marrow stromal precursor cells bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation . J Bone Miner Res. 14:1999;1522-1595.
15. Asahina I., Sampath T.K., Hauschka P.V. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res. 222:1996;38-47.
16. Sottile V., Seuwen K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett. 475:2000;201-204.
17. Wang E.A., Israel D.I., Kelly S., Luxenberg D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors. 9:1993;57-71.
18. ten Dijke P., Miyazono K., Heldin C.H. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci. 25:2000;64-70.
19. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
20. Yingling J.M., Datto M.B., Wong C., Frederick J.P., Liberati N.T., Wang X.F. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol. 17:1997;7019-7028.
21. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kem S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1:1998;611-617.
22. Canalis E., Gabbitas B. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures. J Bone Miner Res. 9:1994;1999-2005.
23. Harada S., Sampath T.K., Aubin J.E., Rodan G.A. Osteogenic protein-1 upregulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence. Mol Endocrinol. 11:1997;1832-1845.
24. Lee M.H., Javed A., Kim H.J., Shin H.I., Gutierrez S., Choi J.Y., et al. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem. 73:1999;114-125.
25. Zheng M.H., Wood D.J., Wysocki S., Papadimitriou J.M., Wang E.A. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-beta 1 genes in normal human osteoblast-like cells. J Cell Physiol. 159:1994;76-82.
26. Hollnagel A., Oehlmann V., Heymer J., Ruther U., Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem. 274:1999;19838-19845.
27. Miyama K., Yamada G., Yamamoto T.S., Takagi C., Miyado K., Sakai M., et al. A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev Biol. 208:1999;123-133.
28. Henningfeld K.A., Rastegar S., Adler G., Knochel W. Smad1 and Smad4 are components of the bone morphogenetic protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter. J Biol Chem. 275:2000;21827-21835.
29. Jonk L.J., Itoh S., Heldin C.H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible inducible enhancer. J Biol Chem. 273:1998;21145-21152.
30. Tang S.J., Hoodless P.A., Lu Z., Breitman M.L., McInnes R.R., Wrana J.L., Buchwald M. The Tlx-2 homeobox gene is a downstream target of BMP signalling and is required for mouse mesoderm development. Development. 125:1998;1877-1887.
31. Littlewood-Evans A., Kokubo T., Ishibashi O., Inaoka T., Wlodarski B., Gallagher J.A., Bilbe G. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone. 20:1997;81-86.
32. Hauser S., Weich H.A. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors. 9:1993;259-268.
33. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.
34. Luttun A., Tiwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 8:2002;831-840.
35. De Falco S., Gigante B., Persico M. Structure and function of placental growth factor. Trends Cardiovasc Med. 12:2002;241.
36. Maglione D., Guerriero V., Viglietto G., Ferraro M.G., Aprelikova O., Alitalo K., et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene. 8:1993;925-931.
37. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 7:2001;575-583.
38. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 8:2002;841-849.
39. Afshari C.A. Perspective microarray technology, seeing more than spots . Endocrinology. 143:2002;1983-1989.
40. Locklin R.M., Riggs B.L., Hicok K.C., Horton H.F., Byrne M.C., Khosla S. Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J Bone Miner Res. 16:2001;2192-2204.
41. Raouf A., Seth A. Discovery of osteoblast-associated genes using cDNA microarrays. Bone. 80:2002;463-471.
42. Kale S., Biermann S., Edwards C., Tarnowski C., Morris M., Long M.W. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol. 18:2000;954-958.
43. Virdi A.S., Cook L.J., Oreffo R.O., Triffitt J.T. Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines. Cell Mol Biol (Noisy-le-grand). 44:1998;1237-1246.
44. Zehentner B.K., Dony C., Burtscher H. The transcription factor Sox9 is involved in BMP-2 signaling. J Bone Miner Res. 14:1999;1734-1741.
45. Raval P., Hsu H.H., Schneider D.J., Sarras M.P. Jr, Masuhara K., Bonewald L.F., Anderson H.C. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells. J Dent Res. 75:1996;1518-1523.
46. Deckers M.M., Karperien M., van Der B.C., Yamashita T., Papapoulos S.E., Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 141:2000;1667-1674.
47. Harper J., Gerstenfeld L.C., Klagsbrun M. Neuropilin-1 expression in osteogenic cells down-regulation during differentiation of osteoblasts into osteocytes . J Cell Biochem. 81:2001;82-92.
48. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:1996;3336-3343.
49. Clauss M., Weich H., Breier G., Knies U., Rockl W., Waltenberger J., Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities implications for a functional role of placenta growth factor in monocyte activation and chemotaxis . J Biol Chem. 271:1996; 17629-17634.
50. Sawano A., Iwai S., Sakurai Y., Ito M., Shitara K., Nakahata T., Shibuya M. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood. 97:2001;785-791.
51. Ishida W., Hamamoto T., Kusanagi K., Yagi K., Kawabata M., Takehara K., Sampath T.K., Kato M., Miyazono K. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem. 275:2000;6075-6079.